期刊文献+

DJ-1 shRNA靶向逆转人乳腺癌阿霉素耐药细胞株MCF-7/ADM的耐药性 被引量:5

DJ-1 shRNA reverses multidrug resistance of human breast cancer Adriamycin resistant cell line MCF-7/ADM
原文传递
导出
摘要 目的探讨干扰癌基因DJ-1表达对人乳腺癌耐药细胞株MCF-7/ADM多药耐药性(multi-drug resistence,MDR)的影响。方法将构建的DJ-1 shRNA真核表达载体,用脂质体转染至人乳腺癌耐药细胞株MCF-7/ADM;用RT-PCR和Western blot法分别检测细胞MDR 1 mRNA和P-糖蛋白(P-glycopro-tein,P-gp)的表达;MTT法检测细胞对化疗药物的敏感性。结果 DJ-1 shRNA靶向干预MCF-7/ADM细胞DJ-1表达后,DJ-1 shRNA组细胞MDR 1 mRNA和P-gp表达水平较空白与阴性对照组明显下降(P<0.0 1);细胞内Adriamycin浓度明显增加;细胞对Adriamycin的敏感性增强2.6 8倍。结论 DJ-1shRNA可降低乳腺癌MCF-7/ADM细胞的MDR,为研究逆转乳腺癌化疗耐药提供了新方法。 Objective To explore the effect of multidrug resistance(MDR) of human breast cancer Adriamycin resistant cell line MCF-7/ADM by interference gene DJ-1 expression.Methods DJ-1shRNA plasmid was transfected into MCF-7/ADM cells by lipofectamine 2000;The mRNA and protein expression level of MDR1 was detected by RT-PCR and Western blot,respectively.The cellular sensitivity to chemotherapeutics was measured by MTT.Results Compared with blank and negative control groups MDR1 mRNA and P-gp expression were reduced after MCF-7/ADM cells interfered by DJ-1 sh′RNA,(all P0.01).The chemosensitivity assays revealed that the transfected cells sensitivity to chemotherapeutics adriamycin was increased 2.68 fold.Conclusions DJ-1shRNA effectively reverses the multidrug resistance of human breast cancer Adriamycin resistant cell line MCF-7/ADM,which provides a novel approach for reversing breast cancer MDR.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2010年第11期1219-1222,共4页 China Journal of General Surgery
基金 湖北省自然科学基金资助项目(2009CBB323) 华中科技大学研究生科技创新基金资助项目(HF-07-58-2010-540)
关键词 DJ-1 RNA干扰 多药耐药 乳腺癌 DJ-1 RNA interference Multidrug resistance Breast cancer
  • 相关文献

参考文献14

  • 1Nagakubo D, Taira T, Kitaura H, et al. D J- 1 , a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras[J]. Biochem Biophys Res Commun, 1997,231 (2) :509 -513.
  • 2Kim RH, Peters M, Jang Y, et al. DJ-1, a novel regulator of the tumor suppressor PTEN [ J ]. Cancer Cell, 2005,7 (3) :263 -273.
  • 3Liu H, Wang M, Li M, et al. Expression and role of DJ-1 in leukemia [ J ]. Biochem Biophys Res Commun, 2008, 375(3) :477 -483.
  • 4Arnal M, Franco N, Fargeot P, et al. Enhancement of mdr 1 gene expression in normal tissue adjacent to advanced breast cancer [J]. Breast Cancer R Treat,2000,61 (1) :13 - 20.
  • 5Rappa G, Finch RA, Sartorelli AC, et al. New insights into the biology an pharmacology of the multidrug resistance protein (MRP) from gene knockout models [ J]. Biochem Pharmacol,1999,58 (4) :557 -562.
  • 6Kobayashi H, Takemura Y, Miyachi H. Novel approaches to revers in anticancer drug resistance using gene-specific therapeutics [J]. Hum Cell,2001,14(3) :172-184.
  • 7MacKeigan JP, Clements CM, Lich JD, et al. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha [ J]. Cancer Res,2003,63 (20) :6928 - 6934.
  • 8Yuen HF, Chan YP, Law S, et al. D J-1 could predict worse prognosis in esophageal squamous cell carcinoma [ J ]. Cancer Epidemiol Biomarkers Prey ,2008,17 ( 12 ) :3593 - 3602.
  • 9Davidson B, Hadar R, Schlossberg A, et al. Expression and clincal role of D J-1 , a negative regulator of PTEN, in ovarian carcinoma [ J ]. Hum Pathol, 2 0 0 8,3 9 ( 1 ) : 8 7 - 9 5.
  • 10Hod Y, Pentyala SN, WhYard TC, et al. Identification and characterization of a novel protein that regulates RNA protein interaction [Jl. J Cell Biochem, 1999,72 (3) :435 - 444.

同被引文献45

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部